Campaign special price starting from 40,000 yen, a collaboration plan between Qiagen and Danaher's since 2022.
Starting from an affordable 40,000 yen, we offer a variety of analysis plans. This plan includes data analysis, USB delivery, and operations on a web portal, making it an astonishingly comprehensive data package. We provide plans that cover everything from read counts to strand information. By utilizing three types of library preparation kits, we can accommodate a wide range of species, from mammals like humans and mice to plants, fish, yeast, and bacteria such as lactic acid bacteria. Common concerns include: - How many reads should I obtain? - Should I focus on full length or the 3' end? - Do I really need strand information? If you're unsure about analysis conditions or plans, please feel free to consult with us.
Inquire About This Product
basic information
Collaboration plan between Qiagen and Danaform. - Library preparation kit: Qiagen QIAseq series - Sequencer: MGI DNBSEQ-g400 - Contract manufacturer: Danaform The "3' transcriptome" is mainly for when you want to know expression levels. The "full-length transcriptome" is for when you want to see both expression levels and splicing variants. This plan is highly recommended as it allows for flexible data mining operations using Qiagen's web portal "RNA-seq Analysis Portal."
Price range
P2
Delivery Time
※Delivery time 5-7 weeks
Applications/Examples of results
Standard data includes RNA expression analysis, transcriptome, splicing variants, and expression levels not only by gene but also by transcript. Fastq Count / FPKM / TPM Comparative analysis data (DEG) Gene ontology Figures (heatmap, dendrogram, MA plot) Files for genome browsers (IGV, UCSC) ⇒ Full package data analysis is standard.
catalog（2）
Download All Catalogs
Company information
Danaform Inc. is a company established in 1998, based on the RIKEN Venture System of the National Research and Development Agency RIKEN, with Yoshihide Hayasaki from RIKEN (who has been the representative director of Danaform Inc. since 2021) at its core. The company is actively engaged in gene analysis and genetic testing, focusing on technologies co-developed by Danaform and RIKEN, including contract analysis using next-generation sequencers such as CAGE-seq and RNA-seq, the sale of fluorescent reagents Eprobe capable of SNP detection, and the sale of various clones, boasting a significant inventory. Moving forward, we aim to refine our proprietary technologies and strive for higher quality research and manufacturing as experts in the field of genetics, with the hope of contributing to people's health.
